Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
24.74
-0.56 (-2.21%)
At close: Aug 25, 2026, 4:00 PM EDT
24.70
-0.04 (-0.16%)
Pre-market: Aug 26, 2026, 5:32 AM EDT
Doximity Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 655.57 | 644.86 | 570.4 | 475.42 | 419.05 | 343.55 | |
Revenue Growth | 11.18% | 13.05% | 19.98% | 13.45% | 21.98% | 66.05% |
Cost of Revenue | 78.23 | 70.33 | 55.87 | 50.67 | 53.49 | 39.79 |
Gross Profit | 577.34 | 574.54 | 514.53 | 424.75 | 365.56 | 303.76 |
Selling, General & Admin | 234.54 | 222.03 | 190.7 | 170.96 | 159.51 | 127.62 |
Research & Development | 142.38 | 130.7 | 93.04 | 81.98 | 80.19 | 62.35 |
Operating Expenses | 376.92 | 352.73 | 283.74 | 252.94 | 239.7 | 189.97 |
Operating Income | 200.43 | 221.81 | 230.78 | 171.81 | 125.87 | 113.79 |
Interest & Investment Income | 32.78 | 35.7 | 35.85 | 21.66 | 9.29 | 2.15 |
Other Non Operating Income (Expenses) | -0.86 | -0.81 | -0.25 | 0.06 | -0.15 | -0.45 |
EBT Excluding Unusual Items | 232.35 | 256.7 | 266.39 | 193.54 | 135.01 | 115.49 |
Merger & Restructuring Charges | -1.19 | -1.62 | - | -7.94 | -0.03 | -0.25 |
Gain (Loss) on Sale of Investments | 0.26 | 0.19 | 0.17 | -0.4 | -1.09 | -1.23 |
Asset Writedown | - | - | -2.3 | - | - | - |
Legal Settlements | -4.85 | -4.85 | - | - | - | - |
Other Unusual Items | -0.34 | -0.42 | -0.68 | - | -0.73 | - |
Pretax Income | 226.22 | 250.01 | 263.57 | 185.2 | 133.16 | 114.01 |
Income Tax Expense | 59.18 | 53.95 | 40.39 | 37.62 | 20.34 | -40.78 |
Net Income | 167.05 | 196.05 | 223.19 | 147.58 | 112.82 | 154.78 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 21.53 |
Net Income to Common | 167.05 | 196.05 | 223.19 | 147.58 | 112.82 | 133.26 |
Net Income Growth | -28.95% | -12.16% | 51.23% | 30.81% | -15.34% | 518.19% |
Shares Outstanding (Basic) | 186 | 187 | 187 | 190 | 193 | 163 |
Shares Outstanding (Diluted) | 197 | 199 | 201 | 206 | 213 | 191 |
Shares Change | -2.55% | -1.07% | -2.20% | -3.60% | 11.73% | 100.79% |
EPS (Basic) | 0.90 | 1.05 | 1.19 | 0.78 | 0.58 | 0.82 |
EPS (Diluted) | 0.84 | 0.98 | 1.11 | 0.72 | 0.53 | 0.70 |
EPS Growth | -27.94% | -11.71% | 54.17% | 35.85% | -24.29% | 204.35% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 306.28 | 326.46 | 273.27 | 183.95 | 177.9 | 124.66 |
Free Cash Flow Per Share | 1.56 | 1.64 | 1.36 | 0.89 | 0.83 | 0.65 |
Gross Margin | 88.07% | 89.09% | 90.20% | 89.34% | 87.23% | 88.42% |
Operating Margin | 30.57% | 34.40% | 40.46% | 36.14% | 30.04% | 33.12% |
Profit Margin | 25.48% | 30.40% | 39.13% | 31.04% | 26.92% | 38.79% |
Free Cash Flow Margin | 46.72% | 50.62% | 47.91% | 38.69% | 42.45% | 36.29% |
EBITDA | 208.4 | 228.79 | 235.64 | 177.08 | 131.35 | 115.33 |
EBITDA Margin | 31.79% | 35.48% | 41.31% | 37.25% | 31.34% | 33.57% |
D&A For EBITDA | 7.98 | 6.98 | 4.86 | 5.27 | 5.48 | 1.54 |
EBIT | 200.43 | 221.81 | 230.78 | 171.81 | 125.87 | 113.79 |
EBIT Margin | 30.57% | 34.40% | 40.46% | 36.14% | 30.04% | 33.12% |
Effective Tax Rate | 26.16% | 21.58% | 15.32% | 20.31% | 15.27% | - |
Advertising Expenses | - | 3.9 | 2.6 | 2.5 | 2.6 | 2.8 |